Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients
I Langer, U Guller, SF Hsu-Schmitz, A Ladewig… - European Journal of …, 2009 - Elsevier
OBJECTIVE: The few long-term follow-up data for sentinel lymph node (SLN) negative
breast cancer patients demonstrate a 5-year disease-free survival of 96–98%. It remains to …
breast cancer patients demonstrate a 5-year disease-free survival of 96–98%. It remains to …
Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
I Langer, U Guller, SF Hsu-Schmitz… - European journal of …, 2009 - folia.unifr.ch
METHODS Three-hundred and fifty-five consecutive node negative patients with early stage
breast cancer (pT1 and pT2< or= 3 cm, pN0/pN (SN) 0) were assessed from our prospective …
breast cancer (pT1 and pT2< or= 3 cm, pN0/pN (SN) 0) were assessed from our prospective …
[PDF][PDF] Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients
I Langer, U Guller, SF Hsu-Schmitz, A Ladewig… - 2008 - academia.edu
Objective: The few long-term follow-up data for sentinel lymph node (SLN) negative breast
cancer patients demonstrate a 5-year diseasefree survival of 96e98%. It remains to be …
cancer patients demonstrate a 5-year diseasefree survival of 96e98%. It remains to be …
Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
I Langer, U Guller, SF Hsu-Schmitz, A Ladewig… - European journal of …, 2009 - sonar.ch
METHODS Three-hundred and fifty-five consecutive node negative patients with early stage
breast cancer (pT1 and pT2< or= 3 cm, pN0/pN (SN) 0) were assessed from our prospective …
breast cancer (pT1 and pT2< or= 3 cm, pN0/pN (SN) 0) were assessed from our prospective …
Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients
I Langer, U Güller, SF Hsu, A Ladewig… - European journal of …, 2009 - boris.unibe.ch
OBJECTIVE: The few long-term follow-up data for sentinel lymph node (SLN) negative
breast cancer patients demonstrate a 5-year disease-free survival of 96-98%. It remains to …
breast cancer patients demonstrate a 5-year disease-free survival of 96-98%. It remains to …
[引用][C] Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients
I Langer, U Guller, SF Hsu-Schmitz, A Ladewig… - European Journal of …, 2009 - cir.nii.ac.jp
Sentinel lymph node biopsy is associated with improved survival compared to level I & II
axillary lymph node dissection in node negative breast cancer patients | CiNii Research CiNii …
axillary lymph node dissection in node negative breast cancer patients | CiNii Research CiNii …
Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients
I Langer, U Guller, SF Hsu-Schmitz… - European Journal of …, 2009 - zora.uzh.ch
OBJECTIVE: The few long-term follow-up data for sentinel lymph node (SLN) negative
breast cancer patients demonstrate a 5-year disease-free survival of 96-98%. It remains to …
breast cancer patients demonstrate a 5-year disease-free survival of 96-98%. It remains to …
Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients
I Langer, U Guller, SF Hsu-Schmitz… - … journal of surgical …, 2009 - pubmed.ncbi.nlm.nih.gov
Objective The few long-term follow-up data for sentinel lymph node (SLN) negative breast
cancer patients demonstrate a 5-year disease-free survival of 96-98%. It remains to be …
cancer patients demonstrate a 5-year disease-free survival of 96-98%. It remains to be …
Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients
I Langer, U Guller, SF Hsu-Schmitz… - European journal of …, 2009 - edoc.unibas.ch
OBJECTIVE: The few long-term follow-up data for sentinel lymph node (SLN) negative
breast cancer patients demonstrate a 5-year disease-free survival of 96-98%. It remains to …
breast cancer patients demonstrate a 5-year disease-free survival of 96-98%. It remains to …
Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
I Langer, U Guller, SF Hsu-Schmitz… - European Journal of …, 2008 - europepmc.org
Objective The few long-term follow-up data for sentinel lymph node (SLN) negative breast
cancer patients demonstrate a 5-year disease-free survival of 96-98%. It remains to be …
cancer patients demonstrate a 5-year disease-free survival of 96-98%. It remains to be …